Gilead Sciences

Gilead Sciences: A Black Box of Uncertainty?
Barron's
Mon, 05/9/16 - 10:41 am
Gilead Sciences
Gilead New CEO Says It's Time to Go Out and Do Important Deals
Bloomberg
Fri, 05/6/16 - 10:49 am
Gilead Sciences
Pharma CEOs
John Milligan
M&A
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead
Forbes
Sat, 04/30/16 - 11:40 am
Amgen
Biogen
Celgene
Gilead Sciences
earnings
2 Attractive Possible Takeovers In Biotech
Seeking Alpha
Sat, 04/30/16 - 10:45 am
M&A
biotech
Gilead Sciences
Relypsa
Ionis Pharmaceuticals
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied
Bloomberg
Sat, 04/30/16 - 10:41 am
Gilead Sciences
Merck
hepatitis C
Harvoni
Sovaldi
Gilead 1Q profit tumbles on slower hepatitis C drug sales
Yahoo/AP
Thu, 04/28/16 - 05:57 pm
Gilead Sciences
earnings
Gilead Earnings Outlook
Seeking Alpha
Thu, 04/28/16 - 09:44 am
Gilead Sciences
earnings
Seven New York insurers end restrictions on coverage for hepatitis C drugs
BioPharma Dive
Wed, 04/27/16 - 09:20 am
New York
insurers
hepatitis C
Merck
Zepatier
Gilead Sciences
Harvoni
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Humira
Amgen
Bristol-Myers Squibb
Coherus Biosciences
Gilead Sciences
Intercept Pharma
JNJ
Novartis
Pfizer
Is Gilead Headed Even Higher?
TheStreet.com
Thu, 04/21/16 - 08:46 am
Gilead Sciences
Why Biotech Will Benefit from Higher Drug Prices
Barron's
Wed, 04/20/16 - 06:41 pm
biotech
drug pricing
JNJ
Gilead Sciences
Amgen
Biogen
New analysis boosts cost-effectiveness argument for Merck's Zepatier
BioPharma Dive
Wed, 04/20/16 - 06:37 pm
Merck
Zepatier
hepatitis C
Harvoni
Gilead Sciences
Merck's 'no patient left behind' approach to hepatitis C
BioPharma Dive
Mon, 04/18/16 - 09:00 pm
Merck
hepatitis C
Zepatier
Gilead Sciences
Sovaldi
Harvoni
Medivation: It’s Not Just M&A
Barron's
Mon, 04/18/16 - 10:15 am
Medivation
M&A
AstraZenca
Sanofi
Gilead Sciences
talazoparib
PARP inhibitors
Gilead Sciences' Two Phase Three Trials Meet Primary Endpoints
Yahoo/Benzinga
Fri, 04/15/16 - 09:00 am
Gilead Sciences
clinical trials
TAF
hepatitis B
This is the most expensive drug in America
Marketwatch
Thu, 04/14/16 - 09:22 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Will Gilead Sciences, Inc (GILD) Shock Everyone With Earnings This Quarter
Bidness, ETC
Wed, 04/13/16 - 09:57 am
Gilead Sciences
earnings
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Medivation
M&A
Amgen
Gilead Sciences
Sanofi
AstraZeneca
Biotech: If M&A is the Answer, What’s the Question?
Barron's
Tue, 04/12/16 - 03:42 pm
biotech
M&A
Amgen
Biogen
Celgene
Gilead Sciences
The FDA Just Approved Another Next-Gen Gilead HIV Drug
Fortune
Tue, 04/5/16 - 10:28 pm
FDA
Descovy
Gilead Sciences
HIV

Pages